The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it strong buy, with a mean price target of $185.
Alibaba Group
9988.HK · HKEX · HKD · Market cap $2.67T
Alibaba Group Holding Limited, through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses in the People's Republic of China and internationally.
PASS · Titan Ethical · score 88.5Screen close, 2026-09-21 · not a live quote
Last reviewed 14 days ago
Screened 2026-09-21 · the tape above runs as of 09:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 112.60 against the desk's fair-value range, base estimate 138.32, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Alibaba Group holds its Markdown at $112.60. The statistical read favours the sellers, held for 37 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 37 days |
| Price at the screen | $112.60 |
| Valuation | 20.22 trailing · 14.69 forward price to earnings |
| Values screen | PASS · score 88.5 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 13.75% | Below 33% | Interest-bearing debt is just 13.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 8.06% | Below 33% | Cash held in interest-bearing accounts and securities is 8.1% of assets, under the one-third limit. | Pass |
| Receivables | 1.73% | Below 49% | Money owed to the company is 1.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.12% | Below 5% | Only 1.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Alibaba clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 14%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 23% discount to our $138.32 fair value, 1.70% revenue growth.
Fair value range in HKD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. A 22.8% margin of safety to the base estimate.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it gives us pause
At 14.7x forward earnings, the price already runs ahead of the business. Our fair value sits at $138.32, below where it trades today.
| Forward P/E | 14.7xexpensive even after accounting for its growth |
| Trailing P/E | 20.2xa premium valuation |
| EPS, trailing | 5.57 |
| EPS, forward | 7.67 |
| Revenue growth | +1.7%slow but positive growth |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | 8.2%a modest return on shareholder capital |
| FCF yield | -0.98% |
| Dividend yield | 0.74% |
| Debt to equity | 0.26minimal debt: a conservative balance sheet |
| Market cap | $2.67T |
The risks · The things to watch: its business and earnings are exposed to Hong Kong and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade9988.HK trades on HKEX (the company is based in Hong Kong). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it strong buy, with a mean price target of $185.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it strong buy, with a mean price target of $185.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it strong buy, with a mean price target of $185.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it strong buy, with a mean price target of $185.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it strong buy, with a mean price target of $185.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | Tsai (Chung Joseph) | Chairman of the Board | 3,333 | · | |
| 2026-04-01 | Wu (Wei) | Director (Non-Executive) | 40,808 | · | |
| 2026-04-01 | Wu (Yongming) | Chief Executive Officer | 13,333 | · | |
| 2026-04-01 | Evans (John Michael) | President | 748,000 | · | |
| 2026-03-26 | Tsai (Chung Joseph) | Chairman of the Board | 1,500,744 | · | |
| 2026-01-01 | Tsai (Chung Joseph) | Chairman of the Board | 3,334 | · | |
| 2026-01-01 | Wu (Yongming) | Chief Executive Officer | 13,334 | · | |
| 2025-12-18 | Lee (Irene Yun-Lien) | Director (Independent) | 5,000 | $92,408 | |
| 2025-12-12 | Tsai (Chung Joseph) | Chairman of the Board | 407,912 | · | |
| 2025-10-01 | Wu (Yongming) | Chief Executive Officer | 13,333 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $133.75 | -15.1% | $1.03 | $856 | -14.4% |
| 2 months | $125.36 | -9.5% | $1.03 | $914 | -8.6% |
| 3 months | $131.45 | -13.7% | $1.03 | $871 | -12.9% |
| 6 months | $153.93 | -26.3% | $1.03 | $744 | -25.6% |
| 1 year | $118.42 | -4.2% | $2.99 | $984 | -1.6% |
| 2 years | $76.64 | +48.1% | $4.61 | $1,541 | +54.1% |
| 3 years | $83.26 | +36.3% | $5.59 | $1,430 | +43.0% |
| 5 years | $203.63 | -44.3% | $5.59 | $585 | -41.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 9988.HK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.